The UK has launched a programme to try to accelerate the discovery and development of new diagnostics and treatments for antimicrobial-resistant (AMR) infections, backed w
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target fo
The UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role of complex cell models were all on the agenda for episode 12 of the
Chief.AI and Medicines Discovery Catapult have been awarded £370,000 of funding from Innovate UK to develop a searchable online platform that aims to make AI accessible to all drug discovery res
GSK looks like it is starting to show the benefit of a revamp of its business under chief executive Emma Walmsley, with recent product launches driving a 10% rise in sales
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.